KYORIN Pharmaceutical Co., Ltd. (4569.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥1,111 (-1.94%) as of
Key statistics
- Market cap
- 63.82B
- P/E (TTM)
- 29.40
- Forward P/E
- 10.58
- EPS (TTM)
- 37.79
- Dividend yield
- 4.15%
- 52-week range
- 1,046.00 – 1,725.00
- Beta
- -0.02
- Revenue (TTM)
- 125.68B
- Profit margin
- 1.73%
- Analyst target
- ¥1,100
- Volume
- 140.90k
About KYORIN Pharmaceutical Co., Ltd.
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Tokyo, Japan
- Employees
- 1,982
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.